Discover open access scientific publications

Search, annotate, share and cite publications

Publications in Pulmonary

P3.08-11 Differences in Evaluations of Early Thorax CT’s Post Lung Stereotactic Body Radiotherapy (SBRT)

Journal of Thoracic Oncology

English

P3.13-31 Creating a Precision Medicine Pipeline for Lung Cancers.

Journal of Thoracic Oncology

English

P2.11-16 Comparison of Two Lung Cancer Screening Programs in One Medical Center - Does Experience of the Screening Team and Indications Affect the Results?

Journal of Thoracic Oncology

English

MA15.11 Real World Biomarker Testing and Treatment Patterns in Patients With Advanced NSCLC Receiving EGFR-TKIs

Journal of Thoracic Oncology

English

P1.09-17 CTNNB1 (Beta-Catenin) Mutations in Non-Small Cell Lung Carcinoma: A Clinicopathological Study of 18 Cases

Journal of Thoracic Oncology

English

MTE23.02 Surgical Considerations Following Induction Therapy for Stage IIIA Disease

Journal of Thoracic Oncology

English

P023 Factors Associated With Administration of Subsequent Cytotoxic Chemotherapy After Nivolumab in Patients With Advanced NSCLC

Journal of Thoracic Oncology

English

A Novel EML6-ALK FBXO11-ALK Double Fusion Variant in Lung Adenocarcinoma and Response to Crizotinib

Journal of Thoracic Oncology

English

P2.03-09 the Real World of NTRK Fusion Data in the Chinese Lung Cancer Populations: A Multicenter Study

Journal of Thoracic Oncology

English

Strong Pharmacological Activity of Locally Administered Next-Generation Antisense Oligonucleotides (ASOs) in Orthotopic Lung Cancer Mouse Models

Journal of Thoracic Oncology

English

Amanote Research

Discover open access scientific publications

Search, annotate, share and cite publications

Publications in Pulmonary

P3.08-11 Differences in Evaluations of Early Thorax CT’s Post Lung Stereotactic Body Radiotherapy (SBRT)

P3.13-31 Creating a Precision Medicine Pipeline for Lung Cancers.

P2.11-16 Comparison of Two Lung Cancer Screening Programs in One Medical Center - Does Experience of the Screening Team and Indications Affect the Results?

MA15.11 Real World Biomarker Testing and Treatment Patterns in Patients With Advanced NSCLC Receiving EGFR-TKIs

P1.09-17 CTNNB1 (Beta-Catenin) Mutations in Non-Small Cell Lung Carcinoma: A Clinicopathological Study of 18 Cases

MTE23.02 Surgical Considerations Following Induction Therapy for Stage IIIA Disease

P023 Factors Associated With Administration of Subsequent Cytotoxic Chemotherapy After Nivolumab in Patients With Advanced NSCLC

A Novel EML6-ALK FBXO11-ALK Double Fusion Variant in Lung Adenocarcinoma and Response to Crizotinib

P2.03-09 the Real World of NTRK Fusion Data in the Chinese Lung Cancer Populations: A Multicenter Study

Strong Pharmacological Activity of Locally Administered Next-Generation Antisense Oligonucleotides (ASOs) in Orthotopic Lung Cancer Mouse Models